Skip Navigation


Rheumatology Advance Access originally published online on August 16, 2005
Rheumatology 2005 44(11):1337-1338; doi:10.1093/rheumatology/kei086
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/11/1337    most recent
kei086v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wise, E. M.
Right arrow Articles by Isaacs, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise, E. M.
Right arrow Articles by Isaacs, J. D.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

EDITORIAL

Management of rheumatoid arthritis in primary care—an educational need?

E. M. Wise1 and J. D. Isaacs2

1 Arthritis Research Campaign Education Research Fellow, University of Newcastle upon Tyne, 2 Professor of Clinical Rheumatology, University of Newscastle, UK

Correspondence to: J. D. Isaacs, Musculoskeletal Research Group, School of Clinical Medical Sciences, 4th Floor Catherine Cookson Building, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. E-mail: j.d.isaacs@ncl.ac.uk

The first 150 words of the full text of this article appear below.

Treatment of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drugs (DMARDs) has proven to be effective at controlling disease activity, reducing joint erosions, reducing cardiovascular mortality and improving quality of life. It is important that patients with RA are reviewed early and considered for treatment with these drugs [1, 2]. The paper by Edwards et al. [3] looks at the use of DMARDs in RA using information from the General Practice Research Database (GPRD). This is a database that currently contains the primary care records of approximately 9 million individuals from almost 400 practices throughout the UK [4]. The practices who contribute data to the GPRD have to meet certain standards for coding/data quality. This paper provides an interesting epidemiological review of the use of DMARDs in primary care using data from the GPRD. It concludes that only 50% of patients coded as . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. G. Grijalva, C. P. Chung, C. M. Stein, E. F. Mitchel Jr, and M. R. Griffin
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
Rheumatology, July 1, 2008; 47(7): 1061 - 1064.
[Abstract] [Full Text] [PDF]